HIV/HCV Coinfection: Why It Matters and What To Do About It

Objectives

  • Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
  • Describe appropriate HCV direct-acting antiviral (DAA) therapies for the treatment of HIV/HCV coinfection Recognize the potential for DAA drug-drug interactions, particularly with HIV antiretroviral therapy
  • Participate in case discussions regarding HCV therapy in HIV/HCV coinfection

Presented by:

Cody A. Chastain, MD

Check all that apply
Check all that apply
By submitting this form, you accept the Mollom privacy policy.

Add comment

Log in to post comments